{
    "organizations": [],
    "uuid": "67a5cad8f4f9e9f25d4d3c39a1cd470dbdb92728",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sangui-biotech-international-q2-op/brief-sangui-biotech-international-q2-operating-loss-shrinks-to-51336-idUSFWN1Q40SR",
    "ord_in_thread": 0,
    "title": "BRIEF-Sangui Biotech International Q2 Operating Loss Shrinks To $51,336",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - SANGUI BIOTECH INTERNATIONAL INC :\n* DGAP-NEWS: SANGUI BIOTECH INTERNATIONAL INC.: - SALES OF USD 55,082 IN THE FIRST HALF-YEAR; - COSTS AND LOSS IS FURTHER REDUCED\n* OPERATING LOSS FOR Q2 OF 2018 DECREASED BY USD 96,386 YEAR-ON-YEAR TO USD 51,336 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-02-14T18:11:00.000+02:00",
    "crawled": "2018-02-15T20:50:19.005+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "sangui",
        "biotech",
        "international",
        "inc",
        "sangui",
        "biotech",
        "international",
        "sale",
        "usd",
        "first",
        "cost",
        "loss",
        "reduced",
        "operating",
        "loss",
        "q2",
        "decreased",
        "usd",
        "usd",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}